Indefinite Delivery Contract SPE2DX15D9200

The federal contract IDV award to DMS Pharmaceutical Group Inc. is a single-award indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The contract has a ceiling value of $499,999,999 and runs through December 31, 2025.

Under this IDC, DMS Pharmaceutical Group, a woman-owned small business, provides a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. The majority of the contract orders are firm fixed-price delivery orders placed by the DLA's Medical Supply Chain division, which then distributes the products to various Department of Defense (DoD) healthcare facilities globally. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying the company's role as a crucial supplier in the federal pharmaceutical supply chain.